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Objectives. This study assessed the useful role of intracardiac 
mapping and radiofrequency catheter ablation in eliminating 
drug-refractory monomorphic ventricular ectopic beats in se- 
verely symptomatic patients. 
Background. Ventricular ectopic activity is commonly encoun- 
tered in clinical practice. Usually, it is not associated with 
life-threatening consequences in the absence of significant struc- 
tural heart disease. However, frequent ventricular ectopic beats 
can be extremely symptomatic and even incapacitating in some 
patients. Currently, reassurance and pharmacologic therapy are 
the mainstays of treatment. There has been little information on 
the use of catheter ablation in such patients. 
Methods. Ten patients with frequent and severely symptomatic 
monomorphic ventricular ectopic beats were selected from three 
tertiary care centers. The mean frequency + SD of ventricular 
ectopic activity was 1,065 + 631 beats/h (range 280 to 2,094) as 
documented by baseline 24-h ambulatory electrocardiographic 
(ECG) monitoring. No other spontaneous arrhythmias were doc- 
umented. These patients had previously been unable to tolerate or 
had been unsuccessfully treated with a mean of 5 -+ 3 antiarrhyth- 
mic drugs. The site of origin of ventricular ectopic activity was 
accurately mapped by using earliest endocardial activation time 
during ectopic activity or pace mapping, or both. 
Results. During eleetrophysiologic study, no patient had induc- 
ible ventricular tachycardia. The ectopic focus was located in the 
right ventricular outflow tract in nine patients and in the left 
ventricular posteroseptal region in one patient. Frequent ventric- 
ular ectopic beats were successfully eliminated by catheter- 
delivered radiofrequeney energy in all 10 patients. The mean number 
of radiofrequency applications was 2.6 -+ 1.3 (range 1 to 5). No 
complications were encountered. During a mean follow-up period of 
l0 -+ 4 months, no patient had a recurrence of symptomatic e topic 
activity, and 24-h ambulatory ECG monitoring showed that the 
frequency of ventricular ectopic activity was 0 beat/h in seven 
patients, 1beat/h in two patients and 2 beats/h in one patient. 
Conclusions. Radiofrequeney catheter ablation can be success- 
fully used to eliminate monomorphic ventricular ectopic activity. 
It may therefore be a reasonable alternative for the treatment of 
severely symptomatic, drug-resistant monomorphic ventricular 
ectopie activity in patients without significant structural heart 
disease. 
(J Am Coil Cardiol 1995;26:843-9) 
Ventricular ectopic activity in the presence of minimal or no 
structural heart disease is commonly encountered in clinical 
practice (1). Although characteristically not associated with 
life-threatening consequences, frequent ventricular ectopic 
beats can be extremely symptomatic and even incapacitating in 
some persons (2). For such patients, reassurance and pharma- 
cologic therapy are currently the mainstays of treatment. The 
development of radiofrequency atheter ablation has provided 
a safe and effective method for curing most types of supraven- 
tricular tachycardias (3-10). In addition, ablation of idiopathic 
vcntricular tachycardias has become a viable alternative to 
drug therapy (11-13). It remains uncertain whether isolated 
monomorphic ventricular ectopic activity can be effectively 
eliminated by catheter-delivered radiofrequency energy. To 
test the hypothesis that monomorphic ventricular ectopic 
activity has a focal origin that can be accurately localized and 
safely eliminated, we performed intracardiac mapping and 
radiofrequency catheter ablation in 10 patients with frequent 
and severely symptomatic monomorphic ventricular ectopic 
beats that failed to be suppressed by multiple medications. 
From the Section of Cardiolo D. Bavlor ('ollegc of Medicine, Houston. 
Texas; Cardiovascular Division, Bowman Gray School ol Medicine. Winstow 
Salem, North Carolina; and +Department of Cardiok W, Cleveland Clinic 
Foundation, Cleveland, Ohio. 
Manuscript received Januao, 2(L 1995: revised manuscript received May l l, 
1995, accepted May 24. 1995. 
Address for correspondence: Dr. Dennis Wci-Xi Zhu, Sectkm of Cardiolog?,, 
Baylor College of Medicine. 6551) Fannin, SM 1246, thmston, Texas 77t)30, 
Methods  
Study patients. The study group comprised 10 patients 
recruited from patients referred for management of symptom- 
atic ventricular ectopic activity at three tertiary care centers 
between January, ]993 and January 1994. The selection criteria 
included l) frequent symptoms that were clearly related to 
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monomorphic ventricular ectopic activity and could not be 
relieved by reassurance; 2) inability of the patient o tolerate or 
unsuccessful treatment with at least three antiarrhythmic 
drugs; 3) no evidence of other cardiac arrhythmias; 4) no 
evidence of significant structural heart disease; 5) absence of 
electrolyte abnormalities, metabolic disorders or advanced 
systemic diseases. The clinical characteristics of the 10 patients 
are shown in Table 1. There were four men and six women, 
with a mean age -+ SD of 46 _+ 10 years (range 29 to 56). Seven 
patients had no apparent structural heart disease; one patient 
had mitral valve prolapse and mild mitral regurgitation, one 
patient had mild left ventricular enlargement with decreased 
left ventricular systolic function (left ventricular ejection frac- 
tion 48%) and one had "focal wall thinning with wall motion 
abnormality of the anterior ight ventricle" by magnetic reso- 
nance imaging. All patients experienced frequent episodes of 
palpitation, fatigue, dyspnea nd light-headedness. The symp- 
toms persisted for a mean of 10 _ 10 years (range 1 to 29). 
Baseline 24-h ambulatory electrocardiographic (ECG) moni- 
toring showed frequent monomorphic ventricular ectopic ac- 
tivity in each patient (mean 1,065 + 631 ventricular ectopic 
beats/h; range 280 to 2,094). Direct correlation between the 
occurrence of symptoms and ventricular ectopic activity was 
documented by means of ambulatory electrocardiography in 
all patients. There were occasional ventricular ectopic ouplets 
and triplets in some patients. No other cardiac arrhythmias 
were documented. The ventricular ectopic beats had a left 
bundle branch block pattern and inferior axis in nine patients 
and a right bundle branch block pattern and superior axis in 
one patient. Because of their disturbing symptoms, all patients 
had frequent clinic visits and multiple hospital admissions to 
initiate or adjust antiarrhythmic drugs for ventricular ectopic 
activity. Patients had previously received a mean of 5 _ 3 
antiarrhythmic drugs (range 3 to 11), including beta-adrenergic 
blocking agents, calcium channel blocking agents, class IA, IB, 
IC and class III agents alone or in combination. These agents 
either could not be tolerated or did not provide adequate 
suppression of ventricular ectopic beats. Thus, intracardiac 
mapping was attempted, and radiofrequenc~j catheter ablation 
was performed to eliminate the site of origin of the monomor- 
phic ventricular ectopic activity in these patients. 
Eleetrophysiologie study. All antiarrhythmic medications 
were discontinued for at least 5 half-lives before baseline 
electrophysiologic evaluations were performed. After written 
informed consent was obtained, standard electrophysiologic 
study was undertaken with the use of local anesthesia and mild 
intravenous edation with the patient in the fasting state. 
Quadripolar electrode catheters (6F) were advanced from the 
right femoral vein and positioned in the low septal right 
atrium, right ventricular apex and outflow tract. A 12-lead 
surface ECG was monitored and recorded on a computer- 
based digital amplifier/recorder system with optical disk stor- 
age (ART, BARD, Biomedical Instrumentation). Bipolar in- 
tracardiac electrograms were filtered with a band-pass of 30 to 
500 Hz. Intracardiac bipolar pacing was performed at twice 
diastolic threshold with a pulse duration of 2.0 ms. Pro- 
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grammed electrical stimulation with up to three extra stimuli at
two drive cycle lengths andrapid burst pacing was performed 
from the right ventricular apex and outflow tract. In seven 
patients, isoproterenol infusion was then initiated at 1 p.g/min 
and increased to a maximal rate of 5 /~g/min i  1-~g/min 
increments o achieve at least a 20% increase in heart rate. 
Programmed lectrical stimulation and rapid burst pacing were 
repeated uring isoproterenol infusion in these patients. The 
frequency of ventricular ectopic activity was compared be- 
tween the baseline state and patients. The frequency of 
ventricular ectopic activity in the baseline state and during 
isoproterenol infusion at the highest dose was compared. 
Mapping and ablation ofventricular ectopic foci. Detailed 
mapping and ablation of the ventricular ectopic focus were 
performed using a 7F or 8F quadripolar catheter with a 
deflectable tip and a 4- or 5-ram distal e ectrode (Webster; EP 
Technology; Elecath). The mapping catheter was introduced 
from the right femoral vein and advanced into the right 
ventricular outflow tract in nine patients with ventricular 
ectopic beats that had a left bundle branch block with inferior 
axis pattern. In the one patient whose ectopic beats had a right 
bundle branch block, superior axis configuration, the mapping 
catheter was introduced from the right femoral artery and 
advanced to the mid-left ventricular septum posteriorly. Hep- 
arin administration was limited to the latter patient. The 
position of the mapping catheter tip was guided fluoroscopi- 
cally with the use of both right and left anterior blique views. 
Mapping for the earliest site of endocardial ctivation during 
spontaneous ventricular ectopic activity was performed ini- 
tially. Pace mapping was performed at endocardial sites show- 
ing early activation (local endocardial potentials earlier than 
the surface QRS recording) during ventricular ectopic activity. 
Bipolar pace mapping was performed between the distal pair 
of electrodes (2-mm spacing). The site of ablation was chosen 
at the site of earliest endocardial ctivation during ventricular 
ectopic activity or from a pace map that best reproduced the 
spontaneous ventricular ectopic configuration on surface 12- 
lead ECG recordings, or both. The power source for endocar- 
dial ablation was a commercially available electrosurgical 
generator that continuously delivered unmodulated radiofre- 
quency current at 500 kHz (model RFG-3C, Radionics). The 
cathode was the distal electrode of the deflectable tip catheter 
used for mapping. The anode was an adhesive cutaneous 
electrocautery dispersive pad placed on the thorax. Radiofre- 
quency energy was delivered at20 to 30 W for 15 to 20 s during 
spontaneous rhythm. If ventricular ectopic beats disappeared 
or its frequency transiently increased, energy application was 
continued for up to 60 s. If a sudden increase in impedance 
occurred, energy delivery was terminated immediately, the 
catheter removed and any adherent coagulum cleaned from 
the tip. Successful ablation was defined as complete limina- 
tion of the spontaneous monomorphic ventricular ectopic 
activity with and without isoproterenol infusion for at least 
30 min after the last application f radiofrequency energy. 
Follow-up. After the ablation procedure, all patients were 
monitored in the hospital for 24 h. An ECG was obtained 
before discharge. Patients were given no antiarrhythmic drugs 
and were evaluated periodically for symptoms at clinic visits. A 
12-lead ECG and 24-h ambulatory ECG monitoring were 
repeated at 3- to 6-month intervals or if the patient had 
symptoms suggestive of recurrence of ventricular ectopic ac- 
tivity. 
Statistical analysis. Continuous variables are presented as 
mean value _+ SD. A paired Student t test was used to analyze 
the statistical significance of reduction of the frequency of 
ventricular ectopic activity on24-h ambulatory ECG monitor- 
ing during follow-up after successful ablation. A two-tailed t 
value -< 0.05 was considered significant. 
Results 
Electrophysiologic study. Spontaneous frequent mono- 
morphic ventricular ectopic activity was present at the time of 
the electrophysiologic study. However, nonsustained or sus- 
tained monomorphic ventricular tachycardias were not induc- 
ible by programmed electrical stimulation in any patient. 
Among the seven patients who received isoproterenol infusion, 
the frequency of ventricular ectopic beats increased in three 
patients, decreased in three and was unchanged in the remain- 
ing patient. Ventricular tachycardia remained noninducible in 
these patients during isoproterenol infusion. 
Mapping and ablation fventricular ectopic foci. In nine 
patients whose ventricular ectopic activity had a left bundle 
branch block configuration with an inferior axis, the site of 
earliest endocardial ctivation during ventricular ectopic activ- 
ity was located in the right ventricular outflow tract (Table 1). 
In two of the nine this site was just below the pulmonary valve 
and one had a focus -1 cm superior to the His bundle. In the 
patient with a right bundle branch block, superior axis pattern, 
the site of earliest endocardial activation was in the left 
ventricular posteroseptal region. In five patients with right 
ventricular outflow tract foci, ablation was guided by endocar- 
dial activation mapping. The earliest endocardial ctivation at 
the target site was 22 to 36 ms (mean 28 _ 7 ms) before the 
onset of the surface ectopic QRS complex (Fig. 1). Pace 
mapping at that site also produced an identical match in all 12 
surface leads. In the other four patients with right ventricular 
outflow tract loci, the ablation was guided by pace mapping. 
Detailed pace mapping was carried out at the endocardial sites 
where local activation time was earlier than the surface QRS 
complex during the ectopic activity. The successful site showed 
an identical QRS complex in all 12 surface leads (Fig. 2). In the 
patient with a left ventricular focus, the earliest endocardial 
activation was located in the posteroseptal region -1 cm from 
the apex and was only 10 ms earlier than the onset of the 
surface QRS complex. Pace mapping at that site produced an 
identical configuration n only 10 of 12 leads. A fascicular 
potential was not observed. Delivery of radiofrequency energy 
at that site eliminated the ectopic activity. After the successful 
ablation, the tip of the ablation catheter was pulled back 
-0.5 cm toward the midposteroseptal region, where a sharp 
deflection preceding local ventricular activation became vi- 
846 ZHU ET AL  JACC Vol. 26, No.  4 
CATHETER ABLATION OF VENTRI('UI,AR ECTOPIC A('TIVITY October 1995:843-9 
I 
II 
III 
aVL 
V1 
V6 
MAP 
' ' ' ' l ' ' ' ' l ' l ' l l ' ' ' ' l ' ' ' ' l ' ' ' ' l ' r ' ' l , , , ' l , , , , I ,~ , , l~ , , , i r , , , i , , , , I , , ,~ l , , , , i , , , T  
/ 
500 msec 
I t 
Figure 1. Patient 1. The earliest ventricular activation during ectopic 
activity was recorded from the distal pair of electrodes (MAP) on a 
quadripolar deflectable mapping catheter (2-5-2-mm interelectrode 
spacing) positioned in the right ventricular outflow tract. As indicated 
by arrows, the onset of local ventricular activation during ventricular 
ectopic activity was 26 ms earlier than the QRS complex on the surface 
electrocardiogram. Delivery of radiofrequency energy at this site 
eliminated the ectopic activity. 
dent, probably representing a fascicular potential. An addi- 
tional application of radiofrequency energy was administered 
at that site. 
In three patients, it was noticed that ventricular ectopic 
activity disappeared transiently when the ablation catheter tip 
was positioned firmly at the successful site before radiofre- 
quency energy was applied. During the delivery of energy, five 
patients had a sudden increase in the frequency of ventricular 
ectopic activity and developed nonsustained ventricular tachy- 
cardia of similar configuration lasting several seconds before 
the ventricular ectopic activity was permanently eliminated 
(Fig. 3). 
The mean number of radiofrequency energy applications 
required for complete limination of ventricular ectopic activ- 
ity was 2.6 _+ 1.3. The duration of radiofrequency application 
before disappearance of ventricular ectopic beats during the
successful ablation was always < 15 s. Energy application was 
then continued for 60 s. An additional application of radiofre- 
quency energy was usually administered atthe same site for 30 
to 60 s after the successful ablation. 
Follow-up. The follow-up data are summarized in Table 1. 
The ventricular ectopic activity was eliminated in all 10 pa- 
tients during the procedure (Fig. 4). The immediate success 
rate was 100%, and no complications were associated with the 
procedure. During a mean follow-up period of 10 _+ 4 months 
(range 6 to 15), no patient had a recurrence of symptomatic 
ectopic activity. Repeat 24-h ambulatory ECG monitoring was 
performed after 3 to 6 months. The frequency of ventricular 
ectopic activity was 0 beat/h in seven patients, I beat/h in two 
patients and 2 beats/h in one patient. The configuration of the 
rare ventricular ectopic beats in the latter patient a follow-up 
was different from that of the original cctopic activity. The 
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Figure 2. Patient 3. Comparison of a 12-lead electrocardiogram with 
spontaneous ventricular ectopic activity (top panel) and a pace map 
(bottom panel) at the successful ablation site in he right ventricular 
outflow tract• Note the nearly identical configuration of thepaced 
ORS complexes and the ventricular ectopic activity in all leads. This 
was the same site at which earliest endocardial activation w s recorded 
during ventricular ectopic activity. 
average frequency of ventricular ectopic activity during 
follow-up (0.4 beats/h) was significantly less than that before 
ablation (1,065 _+ 631 beats/h) (p < 0.0001). The patients did 
not report any symptoms related to the rare ectopic beats. 
Thus, the immediate success of ablation was maintained in the 
intermediate follow-up period. 
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Figure 3. Patient 4. Electrocardiographic tracings. Top, 
Representative tracing of spontaneous ventricular ec- 
topic activity before ablation. Bottom, During radiofre- 
quency energy delivery (RF ON), there was a transient 
increase in the frequency of ventricular ectopic activity 
and development of nonsustained tachycardia of s milar 
configuration followed by permanent elimination of 
ventricular ectopic activity. 
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Discussion 
This study demonstrates that frequent severely symptom- 
atic monomorphic ventricular ectopic activity in patients with- 
out significant structural heart disease originates from a focal 
site that can be accurately localized by intracardiac mapping 
and eliminated successfully by radiofrequency atheter abla- 
tion. All of our patients are free of recurrence during a mean 
follow-up period of 10 ~_ 4 months. 
Ventricular ectopie activity and symptoms. The majority of 
monomorphic ventricular ectopic activity is probably benign, 
especially in younger people. Treatment usually is not neces- 
Figure 4. Ambulatory electrocardiographic tracings 
from Patient 1, who presented with very frequent 
ventricular ectopic beats. Top tracing is representa- 
tive of spontaneous arrhythmia before ablation. Af- 
ter ablation (bottom tracing), all spontaneous ven- 
tricular ectopic beats were eliminated. 
PRE ABLAT ION 
POST ABLAT ION 
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sary. When the ctopic activity s symptomatic, the symptoms 
should first be addressed by allaying the patient's anxiety with 
reassurance. If this is not successful, the frequency of the 
ectopic beats may be reduced by administration of beta- 
blockers, calcium channel blockers or other antiarrhythmic 
agents (14). Ventricular ectopic activity may not always be 
suppressible by antiarrhythmic agents. These agents may have 
potential side effects and may exacerbate the arrhythmias. 
Although radiofrequency atheter ablation has become th  
therapy of choice for drug-refractory idiopathic ventricular 
tachycardia, its role in the managemcnt of symptomatic mono- 
morphic ventricular ectopic activity remains uncertain. Until 
now, only two case reports (15,16) have described three 
patients in whom radiofrequency energy was successfully used 
to eliminate symptomatic "benign" ventricular ectopic activity. 
Our study demonstrated that such drug-resistant frequent 
monomorphic ventricular ectopic activity was effectively elim- 
inated by catheter-delivered radiofrequeney nergy without 
major risk in a series of 10 consecutive symptomatic patients. 
The therapeutic end point for patients with benign but symp- 
tomatic ventricular ectopic activity should be the elimination of 
symptoms. Awareness of ectopic activity varies tr mendously 
from patient to patient. Because symptoms such as palpitation, 
dyspnea, fatigue and dizziness can be quite nonspecific, sub- 
stantiating a causal relation between the symptoms and occur- 
rence of ventricular ectopic activity is crucial before embarking 
on a catheter ablation procedure. In addition, other concurrent 
arrhythmias, such as frequent atrial ectopic activity or parox- 
ysmal atrial fibrillation, need to be ruled out. If these condi- 
tions are met, a high likelihood of symptomatic relief can be 
expected after the elimination of ventricular ectopic activity. In 
our series, ever':, patient had immediate relief of symptoms 
after successful elimination of the ventricular ectopic focus and 
remained asymptomatic during an intermediate follow-up pe- 
riod. 
Ventricular ectopic activity and idiopathic ventricular 
tachycardia. Idiopathic ventricular tachycardia usually origi- 
nates near the right ventricular outflow tract or from the 
posteroseptal aspect of the left ventricle (17). The monomor- 
phic ventricular ectopic activity in our patients originated from 
these similar sites as well. In general, the mechanisms respon- 
sible for the genesis of ventricular ectopic depolarizations are 
controversial nd probably vary from patient o patient. Reen- 
try, abnormal automaticity and triggered activity have been 
postulated (18). In this regard, it should be noticed that during 
idiopathic ventricular tachycardia, there is no evidence for 
isolated mid-diastolic potentials or zones of slow conduction as 
is characteristically found in patients with previous myocardial 
infarction and reentrant ventricular tachycardia (19,2(I). Simi- 
larly, we did not find isolated mid-diastolic potentials in any of 
our 10 patients with ventricular ectopic activity. The lack of 
mid-diastolic potentials i more consistent with a focal mech- 
anism for these arrhythmias, such as abnormal automaticity or
triggered activity, although microreentry inw)lving very small 
circuits cannot be ruled out completely. The similarities re- 
garding configuration, sitc of origin, eleetrophysiologie findings 
and response to therapy suggest hat isolated ventricular 
ectopic activity and sustained ventricular tachycardia probably 
represent the two ends of the spectrum of idiopathic ventric- 
ular arrhythrnias, sharing similar mechanisms and ubstrates. 
Conversion from one to the other has been documented (21). 
Although it has been previously reported (11) that ventricular 
ectopic beats of the same configuration as theventricular 
tachycardia could be used as a target for pace mapping or 
localizing the earliest site ofactivation when clinical sustained 
ventricular tachycardia could not be induced, our series of 
patients is unique in that symptomatic frequent ventricular 
ectopic activity self instead of ventricular tachycardia was the 
target of ablation. Our study shows that both earliest endocar- 
dial activation site and pace mapping can be used to guide the 
ablation of monomorphic ventricular ectopic activity. From 
our limited experience, it appears that the focus of ventricular 
ectopic activity is easier to eliminate than the focus of idio- 
pathic ventricular tachycardia. Although it has been reported 
(11,13) that an average of eight applications of radiofrequency 
energy were quired to ablate idiopathic ventricular tachycar- 
dia foci, two to three applications were usually adequate to 
eliminate ventricular ectopic activity in our series. This obser- 
vation may imply that the idiopathic ventricular ectopic foci 
are smaller or located more superficially in the endocardium. 
Clinical and financial implications. Ventricular ectopic 
activity is probably the most common arrhythmia encountered 
in clinical practice. In symptomatic patients, its impact on 
perceived quality of life can be considerable. Furthermore, 
symptomatic benign ventricular ectopic activity is associated 
with a substantial consumption of health care resources, as 
asserted by the frequent clinic visits, repeated ambulatory 
ECG monitoring and hospital admissions in ourpatients to 
initiate, adjust orchange antiarrhythmic drugs. If our favorable 
short-term outcome of radiofrequency atheter ablation is 
confirmed and extended by other investigators, it may be 
reasonable to prospectively compare early ablation versus 
conventional ntiarrhythmic therapy in patients with severely 
symptomatic monomorphic ventricular ectopic activity, using 
quality of life and medical costs as outcome measures. 
Study limitations. The major limitations of this study are 
the small study group and the relatively short period of 
follow-up. Even though the ffect of radiofrequency atheter 
ablation appears to be sustained in all patients for ->6 months 
after the procedure, the lack of knowledge of long-term 
consequences in these patients necessitates continued follow- 
up. The small number of patients might reflect our stringent 
selection criteria. Although finding no failures in a small group 
of patients is encouraging, it does not guarantee adequate 
safety or etficacy statistically (22,23). With no failure in 10 
patients, the 95% confidence interval for the failure rate may 
still extend up to 30%. Thus, the favorable outcome in our 
patients needs to be confirmed in a larger patient population. 
Our study used no randomized control group for compar- 
ison. However, the frequency of ventricular ectopic activity as 
well as symptoms these patients experienced before the abla- 
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tion has served as an effective means of assessing the efficacy of 
the therapy. 
Ventricular ectopic activity originated in the right ventric- 
ular outflow tract in 9 of our 10 study patients. This observa- 
tion may represent a selection bias, triggered by the prior 
favorable experience in our centers with ablation of ventricular 
tachycardia originating from that region, and its overall easier 
accessibility. However, a predominance of right ventricular 
origin for ventricular ectopic activity in patients without heart 
disease has been well described (24,25). The true incidence of 
right versus left ventricular origin in patients with benign 
ventricular ectopic activity needs further clarification. 
Conclusions. Radiofrequency catheter ablation appeared 
to be an appropriate management option for our 10 patients 
with symptomatic, drug-resistant monomorpbic ventricular ec- 
topic activity. The ventricular cctopic loci were located in the 
right ventricular outflow tract in the majority of patients. The 
mapping and ablation techniques used are similar to those 
used for idiopathic ventricular tachycardia. Although the pro- 
cedures were performed by multiple operators from different 
centers, the success rate was high and no complications 
occurred. The symptoms related to frequent ventricular ec- 
topic activity were resolved. Appropriate selection of patients 
is important to achieve an optimal clinical outcome. Until 
further experience is accumulated, we believe that this thera- 
peutic approach should be performed by experienced electro- 
physiologists and reserved for severely symptomatic patients 
who do not respond to standard treatment. 
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